Literature DB >> 21633168

FGF-dependent regulation of VEGF receptor 2 expression in mice.

Masahiro Murakami1, Loc T Nguyen, Kunihiko Hatanaka, William Schachterle, Pei-Yu Chen, Zhen W Zhuang, Brian L Black, Michael Simons.   

Abstract

Numerous studies have suggested a link between the angiogenic FGF and VEGF signaling pathways; however, the nature of this link has not been established. To evaluate this relationship, we investigated VEGF signaling in ECs with disrupted FGF signaling in vitro and in vivo. ECs lacking FGF signaling became unresponsive to VEGF, caused by downregulation of VEGF receptor 2 (VEGFR2) expression after reduced Vegfr2 enhancer activation. FGF mediated VEGFR2 expression via activation of Erk1/2. Transcriptional analysis revealed that Ets transcription factors controlled VEGFR2 expression in an FGF- and Erk1/2-dependent manner. Mice with defective FGF signaling exhibited loss of vascular integrity and reduced vascular morphogenesis. Thus, basal FGF stimulation of the endothelium is required for maintenance of VEGFR2 expression and the ability to respond to VEGF stimulation and accounts for the hierarchic control of vascular formation by FGFs and VEGF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633168      PMCID: PMC3223828          DOI: 10.1172/JCI44762

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo.

Authors:  Jean-Philippe Gratton; Jun Yu; Jason W Griffith; Roger W Babbitt; Ramona S Scotland; Reed Hickey; Frank J Giordano; William C Sessa
Journal:  Nat Med       Date:  2003-02-24       Impact factor: 53.440

3.  HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells.

Authors:  Yaxu Wu; Martin Moser; Victoria L Bautch; Cam Patterson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

4.  VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.

Authors:  Myriam Grunewald; Inbal Avraham; Yuval Dor; Esther Bachar-Lustig; Ahuva Itin; Steffen Jung; Steffen Yung; Stephano Chimenti; Limor Landsman; Rinat Abramovitch; Eli Keshet
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

5.  Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.

Authors:  P Auguste; D B Gürsel; S Lemière; D Reimers; P Cuevas; F Carceller; J P Di Santo; A Bikfalvi
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

6.  Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.

Authors:  Mitsuho Onimaru; Yoshikazu Yonemitsu; Mitsugu Tanii; Kazunori Nakagawa; Ichiro Masaki; Shinji Okano; Hiroaki Ishibashi; Kanemitsu Shirasuna; Mamoru Hasegawa; Katsuo Sueishi
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

7.  Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

Authors:  Ichiro Masaki; Yoshikazu Yonemitsu; Akihisa Yamashita; Shihoko Sata; Mitsugu Tanii; Kimihiro Komori; Kazunori Nakagawa; Xiaogang Hou; Yoshiyuki Nagai; Mamoru Hasegawa; Keizo Sugimachi; Katsuo Sueishi
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

8.  Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

Authors:  Hajime Kubo; Renhai Cao; Ebba Brakenhielm; Taija Mäkinen; Yihai Cao; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

9.  Deregulation of Flk-1/vascular endothelial growth factor receptor-2 in fibroblast growth factor receptor-1-deficient vascular stem cell development.

Authors:  Peetra Magnusson; Charlotte Rolny; Lars Jakobsson; Charlotte Wikner; Yan Wu; Daniel J Hicklin; Lena Claesson-Welsh
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

10.  Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt.

Authors:  Shigeru Kanda; Yasuyoshi Miyata; Hiroshi Kanetake
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

View more
  83 in total

1.  Angiopoietin-1 prevents severe bleeding complications induced by heparin-like drugs and fibroblast growth factor-2 in mice.

Authors:  Marina Jerebtsova; Jharna R Das; Pingtao Tang; Edward Wong; Patricio E Ray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-14       Impact factor: 4.733

2.  Fibroblast growth factor acts upon the transcription of phospholipase C genes in human umbilical vein endothelial cells.

Authors:  Vincenza Rita Lo Vasco; Martina Leopizzi; Chiara Puggioni; Carlo Della Rocca; Rita Businaro
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

Review 3.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  VEGFR1 and VEGFR2 in lip carcinogenesis and its association with microvessel density.

Authors:  Carla Ariotti; Vivian Petersen Wagner; Gabriela Salvadori; Vinicius Coelho Carrard; Marco Antônio Trevizani Martins; Joao Julio da Cunha Filho; Luise Meurer; Manoela Domingues Martins
Journal:  Tumour Biol       Date:  2015-04-21

Review 5.  Fibroblast growth factor signaling in the vasculature.

Authors:  Xuehui Yang; Lucy Liaw; Igor Prudovsky; Peter C Brooks; Calvin Vary; Leif Oxburgh; Robert Friesel
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

Review 6.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

7.  Platelet neuropeptide Y is critical for ischemic revascularization in mice.

Authors:  Jason U Tilan; Lindsay M Everhart; Ken Abe; Lydia Kuo-Bonde; Dan Chalothorn; Joanna Kitlinska; Mary Susan Burnett; Stephen E Epstein; James E Faber; Zofia Zukowska
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

8.  Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.

Authors:  Hanseul Yang; Sungsu Lee; Seungjoo Lee; Kangsan Kim; Yeseul Yang; Jeong Hoon Kim; Ralf H Adams; James M Wells; Sean J Morrison; Gou Young Koh; Injune Kim
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

9.  PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.

Authors:  S W Huang; J C Lien; S C Kuo; T F Huang
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

10.  An integrated approach to quantitative modelling in angiogenesis research.

Authors:  Anthony J Connor; Radosław P Nowak; Erica Lorenzon; Markus Thomas; Frank Herting; Stefan Hoert; Tom Quaiser; Eliezer Shochat; Joe Pitt-Francis; Jonathan Cooper; Philip K Maini; Helen M Byrne
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.